课题基金 / 基金详情

SMART (Smallpox vaccine for Mpox Post-Exposure Prophylaxis: A Cluster Randomized Controlled Trial)

SMART (Smallpox vaccine for Mpox Post-Exposure Prophylaxis: A Cluster Randomized Controlled Trial)
SMART(用于 Mpox 暴露后预防的天花疫苗:集群随机对照试验)
批准号:
481134
负责人:
Loeb Mark B
金额:
$36.43万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
已结题
起止时间:
2023-02-01 至 2024-10-01

项目摘要

项目成果

Loeb Mark B的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It is important to determine how effective smallpox vaccine is in preventing illness in household members exposed to someone with mpox when given after exposure. There are no studies that have compared people vaccinated after such exposure with those who
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Research Chair - Tier 1
  • 批准号:
    459643
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2021
  • 负责人:
    Loeb Mark B
  • 依托单位:
Determinants of Community COVID Transmission: Learning from the Hutterites
  • 批准号:
    430339
  • 项目类别:
    Operating Grants
  • 资助金额:
    $108.0万
  • 财政年份:
    2020
  • 负责人:
    Loeb Mark B
  • 依托单位:
Medical Masks versus N95 Respirators to Prevent COVID-19 in Healthcare Workers: A Randomized Trial
  • 批准号:
    429734
  • 项目类别:
    Operating Grants
  • 资助金额:
    $45.53万
  • 财政年份:
    2020
  • 负责人:
    Loeb Mark B
  • 依托单位:
Towards a better understanding of Influenza Vaccination: Lessons from the Hutterite Community
  • 批准号:
    333613
  • 项目类别:
    Operating Grants
  • 资助金额:
    $605.42万
  • 财政年份:
    2015
  • 负责人:
    Loeb Mark B
  • 依托单位: